Cervical abnormalities (CIN3/CGIN): recurrence of abnormal cells

Treatment for CIN is very effective and, in most cases, successful first time. Many of the women we interviewed, though, were anxious about recurrence after treatment and would have liked more information about it.

A doctor explains that the chances of recurrence after treatment for CIN3 / CGIN are small.

Gender Female

View profile

Jane feels she would have worried less if shed known the chances of recurrence were low. She…

Age at interview 45

Gender Female

Age at diagnosis 35

View profile

A few women we spoke interviewed did have a recurrence of abnormal cells after treatment for CIN3, and this was often found at a follow-up appointment. Most were treated again by LLETZ.

Susan was shocked to have CIN3 again. She wondered why it had recurred and how long it took for…

Age at interview 31

Gender Female

Age at diagnosis 25

View profile

Sarahs doctor was very good and referred her for treatment quickly when abnormalities were found…

Age at interview 37

Gender Female

Age at diagnosis 24

View profile

Some of the women who had a recurrence said they were given sufficient information and felt reassured that the abnormal cells would be treated quickly and successfully. Others, though, were very disappointed and upset when they were told they would need more treatment.

Anna was shocked when, at a follow-up appointment, more abnormal cells were found. She was…

Age at interview 29

Gender Female

Age at diagnosis 28

View profile

Jo knew what to expect when she had to have another LLETZ but that didnt make it any easier. The…

Age at interview 33

Gender Female

Age at diagnosis 25

View profile

Some of the women we talked to compared the treatment they’d had in the past with their second experience. Jane had a recurrence exactly twenty years after her first diagnosis. She preferred having a LLETZ to laser treatment and said, second time around, she was given more information and empathy. Debbie, though, was disappointed with the information and care she was given. She had a LLETZ twice because there were no clear margins after her first treatment. A few years later, she was treated by cone biopsy.

Jane had a LLETZ and found it better than laser treatment. The technology had improved and…

Age at interview 50

Gender Female

Age at diagnosis 30

View profile

Debbie had a reaction to the local anaesthetic on two occasions but, this time, was left on her…

Age at interview 36

Gender Female

Age at diagnosis 24

View profile

Ruth had abnormal cells several times over fourteen years or so. It was a ‘constant worry’ for her and, later, she was also treated for VIN3. VIN stands for ‘vulval intraepithelial neoplasia’ and means there are precancerous changes in the skin cells of the vulva.

Living with abnormal cells was worrying and Ruth never felt reassured when she was told she was…

Age at interview 41

Gender Female

Age at diagnosis 28

View profile

Most women said their anxieties about recurrence lessened over time, the longer they had been clear. They were pleased to have regular follow-up care because they felt that, if they did have abnormal cells again, these would be found and treated early (see ‘Follow-up care‘).

HPV as a ‘test of cure’

The NHS Cervical Screening Programme is introducing an HPV ‘Test of Cure’ for women who have undergone treatment for cervical abnormalities (CIN 1, 2 or 3). When women return for follow up screening, after treatment, if the test shows normal, borderline or mild screening results, the sample will also be tested for HPV. If HPV is detected or the screening test shows an abnormality, women will be referred again to colposcopy. If the screening result is normal and the HPV result is negative, women will return to routine recall for cervical screening every 3 years. This new policy aims to reduce the need for up to 10 years of annual cervical screening.

Cervical abnormalities: follow-up care

Many of the women we interviewed talked about having follow-up care a few months after treatment. A colposcopy and cervical screening test (smear) are usually...